BridgeBio Pharma Inc.
Last updated September 27, 2026
Organization details
- Legal name
- BridgeBio Pharma Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- BBIO
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001743881
Board of directors
-
Ali J. Satvat · DirectorSince 2023
-
Andrea Ellis · DirectorSince 2023
-
Andrew Lo · DirectorSince 2023
-
Charles J. Homcy · DirectorSince 2023
-
Douglas A. Dachille · DirectorSince 2023
-
Eric Aguiar · DirectorSince 2023
-
Frank Mccormick · DirectorSince 2023
-
Fred Hassan · DirectorSince 2023
-
Hannah Valantine · DirectorSince 2023
-
James C. Momtazee · DirectorSince 2023
-
Jennifer E. Cook · DirectorSince 2023
-
Neil Kumar · Director · CEO and PresidentSince 2023
-
Randal W. Scott · DirectorSince 2023
-
Richard H. Scheller · DirectorSince 2023
-
Ronald J. Daniels · DirectorSince 2023
Chief executives
Neil Kumar
· CEO and President
Dates unknown
Board connections
6 of this board's directors also sit on 9 other boards.
- via Richard H. Scheller
- via Eric Aguiar
- via Hannah Valantine
- via Fred Hassan
- via Jennifer E. Cook
- via Jennifer E. Cook
- via Hannah Valantine
- via Fred Hassan
- via James C. Momtazee
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 5, 2023 | Randal W. Scott Director | Open-market sale | −2,500 | $30.00 | $75,000 |
| Aug 17, 2023 | STEPHENSON BRIAN C Officer (Secretary, Treasurer & CFO) | Open-market sale | −22,683 | $28.59 | $648,507 |
| Aug 17, 2023 | Neil Kumar Director, Officer (CEO and President) | Open-market sale | −51,552 | $28.59 | $1,473,872 |
| Aug 16, 2023 | Charles J. Homcy Director | Option exercise | +3,760 | — | — |
| Aug 16, 2023 | STEPHENSON BRIAN C Officer (Secretary, Treasurer & CFO) | Option exercise | +44,994 | — | — |
| Aug 16, 2023 | Neil Kumar Director, Officer (CEO and President) | Option exercise | +102,250 | — | — |
| Aug 16, 2023 | Charles J. Homcy Director | Shares withheld for tax | −1,301 | $29.80 | $38,770 |
| Aug 16, 2023 | STEPHENSON BRIAN C Officer (Secretary, Treasurer & CFO) | Shares withheld for tax | −22,311 | $29.80 | $664,868 |
| Aug 16, 2023 | Neil Kumar Director, Officer (CEO and President) | Shares withheld for tax | −50,698 | $29.80 | $1,510,800 |
| Jul 18, 2023 | Viking Global Opportunities GP LLC 10% owner | Open-market sale | −1,500,000 | $35.00 | $52,500,000 |
| May 17, 2023 | Neil Kumar Director, Officer (CEO and President) | Open-market sale | −51,552 | $14.01 | $722,244 |
| May 17, 2023 | STEPHENSON BRIAN C Officer (Secretary, Treasurer & CFO) | Open-market sale | −24,424 | $14.01 | $342,180 |
| May 16, 2023 | Neil Kumar Director, Officer (CEO and President) | Option exercise | +102,249 | — | — |
| May 16, 2023 | Charles J. Homcy Director | Option exercise | +3,759 | — | — |
| May 16, 2023 | STEPHENSON BRIAN C Officer (Secretary, Treasurer & CFO) | Option exercise | +44,996 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.